Review: taking Ciprofloxacin and Methylprednisolone together


Summary

Drug interactions are reported among people who take Ciprofloxacin and Methylprednisolone together. This review analyzes the effectiveness and drug interactions between Ciprofloxacin and Methylprednisolone. It is created by eHealthMe based on reports of 221 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Ciprofloxacin and Methylprednisolone >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Ciprofloxacin

Ciprofloxacin has active ingredients of ciprofloxacin. It is often used in pneumonia. (latest outcomes from Ciprofloxacin 31 users)

Methylprednisolone

Methylprednisolone has active ingredients of methylprednisolone. It is often used in rheumatoid arthritis. (latest outcomes from Methylprednisolone 19,250 users)

On Jul, 24, 2016

221 people who take Ciprofloxacin, Methylprednisolone are studied.


Number of reports submitted per year:

Ciprofloxacin and Methylprednisolone drug interactions.

Drug effectiveness over time:

Ciprofloxacin:
  • < 1 month: 0.0% - (0 of 3 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 1 people)
Methylprednisolone:
  • < 1 month: 0.0% - (0 of 3 people)
  • 1 - 6 months: 100.0% - (1 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Ciprofloxacin:
  • female: 0.0% - (0 of 3 people)
  • male: 0.0% - (0 of 1 people)
Methylprednisolone:
  • female: 33.0% - (1 of 3 people)
  • male: 0.0% - (0 of 1 people)

Drug effectiveness by age:

Ciprofloxacin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 1 people)
Methylprednisolone:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 100.0% - (1 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • restlessness
  • pain in extremity
  • fatigue
  • screaming
  • tracheobronchitis
  • disorientation
  • fall
  • crohn's disease
  • intestinal stenosis
  • acute abdomen
1 - 6 months:
  • pain in extremity
  • plantar fasciitis
  • tendonitis
  • transplant rejection
not specified:
  • pain
  • anxiety
  • fatigue
  • nausea
  • osteonecrosis of jaw
  • injury
  • osteoarthritis
  • arthralgia
  • weight decreased
  • back pain

Most common drug interactions by gender *:

female:
  • nausea
  • fatigue
  • anxiety
  • bronchitis
  • bone disorder
  • dyspnoea
  • osteonecrosis of jaw
  • arthralgia
  • lymphadenopathy
  • pain
male:
  • pain
  • injury
  • anxiety
  • fatigue
  • osteonecrosis of jaw
  • osteoarthritis
  • anhedonia
  • arthralgia
  • malaise
  • back pain

Most common drug interactions by age *:

2-9:
  • bronchiolitis
  • fatigue
  • hypertrophic obstructive cardiomyopathy
  • irritability
  • liver function tests nos abnormal
10-19:
  • nausea
  • anorexia
  • benign intracranial hypertension
  • chest pain
  • difficulty in walking
  • fall
  • hypoaesthesia
  • loss of consciousness
  • weight decreased
  • headache
20-29:
  • crohn's disease
  • intestinal stenosis
  • cardiac disorder
  • hypoglycaemia
  • migraine
  • type 1 diabetes mellitus
  • antinuclear antibody positive
  • ascites
  • blood cholesterol abnormal
  • blood creatinine increased
30-39:
  • fatigue
  • diabetes mellitus
  • hypertension
  • abdominal pain
  • amnesia
  • anaemia
  • arthritis
  • asthma
  • bone pain
  • cardiac murmur
40-49:
  • cytomegalovirus infection
  • nausea
  • dehydration
  • oesophageal candidiasis
  • anxiety
  • diarrhoea
  • pain
  • pyrexia
  • chest discomfort
  • dysarthria
50-59:
  • arthralgia
  • mouth ulceration
  • pain
  • pain in jaw
  • sinusitis
  • constipation
  • osteonecrosis of jaw
  • bronchitis
  • fatigue
  • pancytopenia
60+:
  • anxiety
  • pain
  • osteoarthritis
  • osteonecrosis of jaw
  • injury
  • fatigue
  • back pain
  • bone disorder
  • gingival swelling
  • weight decreased

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Ciprofloxacin and Methylprednisolone?


Recent conversations of related support groups:

Can you answer these questions?

More questions for: Ciprofloxacin, Methylprednisolone

You may be interested in these reviews

More reviews for: Ciprofloxacin, Methylprednisolone

On eHealthMe, Ciprofloxacin (ciprofloxacin) is often used to treat pneumonia. Methylprednisolone (methylprednisolone) is often used to treat rheumatoid arthritis. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.